| microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma B Kefas, J Godlewski, L Comeau, Y Li, R Abounader, M Hawkinson, J Lee, ... Cancer research 68 (10), 3566-3572, 2008 | 913 | 2008 |
| MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes Y Li, F Guessous, Y Zhang, C DiPierro, B Kefas, E Johnson, ... Cancer research 69 (19), 7569-7576, 2009 | 716 | 2009 |
| microRNA-34a is tumor suppressive in brain tumors and glioma stem cells F Guessous, Y Zhang, A Kofman, A Catania, Y Li, D Schiff, B Purow, ... Cell cycle 9 (6), 1031-1036, 2010 | 396 | 2010 |
| Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis R Abounader, J Laterra Neuro-oncology 7 (4), 436-451, 2005 | 369 | 2005 |
| The p53 pathway in glioblastoma Y Zhang, C Dube, M Gibert Jr, N Cruickshanks, B Wang, M Coughlan, ... Cancers 10 (9), 297, 2018 | 319 | 2018 |
| Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells DI Bannon, R Abounader, PSJ Lees, JP Bressler American Journal of Physiology-Cell Physiology 284 (1), C44-C50, 2003 | 267 | 2003 |
| The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors B Kefas, L Comeau, DH Floyd, O Seleverstov, J Godlewski, T Schmittgen, ... Journal of Neuroscience 29 (48), 15161-15168, 2009 | 263 | 2009 |
| In vivo targeting of SF/HGF and c‐met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis R Abounader, B Lal, C Luddy, G Koe, B Davidson, EM Rosen, J Laterra The FASEB Journal 16 (1), 1-16, 2002 | 251 | 2002 |
| Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase-and AKT-dependent pathways DC Bowers, S Fan, KA Walter, R Abounader, JA Williams, EM Rosen, ... Cancer Research 60 (15), 4277-4283, 2000 | 221 | 2000 |
| Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression R Abounader, S Ranganathan, B Lal, K Fielding, A Book, H Dietz, ... Journal of the National Cancer Institute 91 (18), 1548-1556, 1999 | 221 | 1999 |
| Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ... Neuro-oncology 18 (11), 1529-1537, 2016 | 203 | 2016 |
| Oncogenic effects of miR-10b in glioblastoma stem cells F Guessous, M Alvarado-Velez, L Marcinkiewicz, Y Zhang, J Kim, ... Journal of neuro-oncology 112, 153-163, 2013 | 172 | 2013 |
| Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis ME Beckner, GT Gobbel, R Abounader, F Burovic, NR Agostino, J Laterra, ... Laboratory investigation 85 (12), 1457-1470, 2005 | 153 | 2005 |
| BIIE0246, a potent and highly selective non‐peptide neuropeptide Y Y2 receptor antagonist Y Dumont, A Cadieux, H Doods, LH Pheng, R Abounader, E Hamel, ... British journal of pharmacology 129 (6), 1075-1088, 2000 | 142 | 2000 |
| XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC Y Zhang, F Guessous, A Kofman, D Schiff, R Abounader IDrugs 13 (2), 112, 2010 | 133 | 2010 |
| microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma J Kim, Y Zhang, M Skalski, J Hayes, B Kefas, D Schiff, B Purow, S Parsons, ... Cancer research 74 (5), 1541-1553, 2014 | 132 | 2014 |
| Targeting the c-Met pathway potentiates glioblastoma responses to γ-radiation B Lal, S Xia, R Abounader, J Laterra Clinical cancer research 11 (12), 4479-4486, 2005 | 132 | 2005 |
| The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy Y Li, B Lal, S Kwon, X Fan, U Saldanha, TE Reznik, EB Kuchner, ... Cancer research 65 (20), 9355-9362, 2005 | 126 | 2005 |
| The role of microRNAs in glioma initiation and progression Y Zhang, A Dutta, R Abounader Frontiers in bioscience: a journal and virtual library 17, 700, 2012 | 118 | 2012 |
| PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations Y Li, F Guessous, S Kwon, M Kumar, O Ibidapo, L Fuller, E Johnson, B Lal, ... Cancer research 68 (6), 1723-1731, 2008 | 117 | 2008 |
John LaterraKennedy Krieger Institute & Johns Hopkins School of MedicineGeverifieerd e-mailadres voor kennedykrieger.org
